Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
MYPI2025005270A0Undetermined Publication Date: 2014-06-07GERON CORP
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025005270
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2013-11-05
- Filing Date
- 2013-11-15
- Publication Date
- 2014-06-07
Abstract
Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have myeloproliferative disorders, such as Essential Thrombocythemia (ET). Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having myeloproliferative disorder s, such as ET. Fig. 1
Need to check novelty before this filing date? Find Prior Art
